Huaqing Min, M.D. Professor, Chief Scientist of Department of NPC, Council Member of Chinese Anticancer Association, President of Chinese Society for NPC.
Address:
Department of NPC Cancer Center, zhongshan University 
651 Dongfeng East Road  
Guangzhou 510060
Tel: +86-20-87765368 ext. 5211
Fax: +86-20-87754506


Biography:
    Dr. Min received his M.D. from SUMS in 1956. Between 1956 to 1961, he worked for the Second Affiliated Hospital, SUMS as a resident and doctor in charge in the ENT department. Since 1961 to 1989 turned to the Cancer Center as a lecturer, associate professor, and professor. In this period, Dr. Min took part in the clinical and epidemio-
logical survey on cancer, especially on nasopharyngeal carcinoma (NPC). In seventies, Dr. Min, as a member of the organizing committee, participated the retrospective investigation on the canses of tumor death in Guangdong province, also in 1977 to 1978 cooperating with the research workers of Guangsi, Hunan, Fujian, Jiangxi provinces analyzed geographical distribution of NPC in south China. Comparative risk areas of NPC were showed by these studies. Dynamical observation in Guangzhou city during the years of 1972 to 1987 was obtained. This data revealed that the incidence rate, age peak,
sex predilection, histopathological type constitution were fluctuated slightly and the etiological factors of NPC might be stable in nature for a long time. Meanwhile, some case-control studies had been completed. Since 1964, various clinical trials of chemotherapy for advanced NPC had been applied, including intravenous and intra-arterial perfusion of various chemotherapuetic drugs. Multiple modality combination therapeutic strategy was also been explored under the charge of Dr. Min, including the combination of radiotherapy, surgery, and Chinese herbal drugs. A new clinical staging of NPC (named '92 NPC staging) is proposed by Dr. Min et al and is widely used in China. Presently, some key research projects are being conducted: 1. A study on optimal comprehensive treatment modality for NPC; 2. Determination of precancerous status and early detection of high risk individuals for NPC; 3. A comparison study on NPC between Southern and Northern China.
 
Recent publications:
Proposition of a new clinical staging system of nasopharyngeal carcinoma.
    Chung Hua Chung Liu Tsa Chih 1992; 14(5): 388-389.
Advance in nasopharyngeal carcinoma research.
    Foreign Med in Oncol Section (Chinese) 1993; 20(4): 214.
A new staging system for nasopharyngeal carcinoma in China.
    Int J Radiat Oncol Biol Phys 1994; 30: 1037-1042.
Primary study of neovasculature correlating with metastatic nasopharyngeal carcinoma using computer image analysis.
    J Cancer Res Clin Oncol 1997; 123: 645-651.
Stratification comprehensive treatment of nasopharyngeal carcinoma.
    Bull Chinese Cancer 1997; 6: 16.
Editor of the monograph entitled New Edition on the Standard of Diagnosis and Treatment of Nasopharyngeal Carcinoma,1998.
    Editor of the monograph entitled Research on Nasopharyngeal Carcinoma, 1998.